Potassium disorders: hypokalemia and hyperkalemia

MJ Kim, C Valerio, GK Knobloch - American Family Physician, 2023 - aafp.org
Hypokalemia is caused by decreased intake, renal losses, gastrointestinal losses, or
transcellular shifts. Diuretics are among the most common causes of hypokalemia …

Synergistic Machine Learning Accelerated Discovery of Nanoporous Inorganic Crystals as Non‐Absorbable Oral Drugs

L Xiang, J Chen, X Zhao, J Hu, J Yu, X Zeng… - Advanced …, 2024 - Wiley Online Library
Abstract Machine learning (ML) has taken drug discovery to new heights, where effective ML
training requires vast quantities of high‐quality experimental data as input. Non‐absorbable …

Management of hyperkalemia: Expert consensus from Kuwait–a Modified Delphi Approach

A AlSahow, B Bulbanat, B Alhelal… - … of Nephrology and …, 2024 - Taylor & Francis
Introduction Hyperkalemia is common in heart failure (HF) patients on renin angiotensin
aldosterone inhibitors (RAASi), in chronic kidney disease (CKD), and in hemodialysis, and it …

[HTML][HTML] Перспективные направления лечения хронической сердечной недостаточности: совершенствование старых или разработка новых?

ВВ Калюжин, АТ Тепляков, ИД Беспалова… - Бюллетень …, 2022 - cyberleninka.ru
Беспрецедентные достижения последних десятилетий в области клинической
фармакологии, кардиохирургии и имплантационной аритмологии значительно …

[HTML][HTML] Heart Failure and Worsening Renal Function: Prevalence, Risk Factors, and Impact on Hospital Readmissions in an Urban Minority Population

A AlShammari, M Magdits, R Majdalani… - Journal of Clinical …, 2025 - mdpi.com
Background and Objectives: Heart failure (HF) often leads to worsening renal function
(WRF), negatively impacting patient outcomes. This study aims to examine the incidence of …

Impact of treatment of hyperkalaemia on quality of life: design of a prospective observational cohort study of long-term management of hyperkalaemia in patients with …

Y Shibagaki, H Yamazaki, T Wakita, JE Ware… - BMJ open, 2023 - bmjopen.bmj.com
Introduction Hyperkalaemia (HK) is a frequent complication in patients with chronic kidney
disease (CKD) and/or chronic heart failure (CHF). HK must be managed, both to protect …

[PDF][PDF] Promising directions in the treatment of chronic heart failure: improving old or developing new ones?

VV Kalyuzhin, AT Teplyakov… - Bulletin of Siberian …, 2022 - researchgate.net
Unprecedented advances of recent decades in clinical pharmacology, cardiac surgery,
arrhythmology, and cardiac pacing have significantly improved the prognosis in patients with …

[HTML][HTML] Protocol: Impact of treatment of hyperkalaemia on quality of life: design of a prospective observational cohort study of long-term management of …

Y Shibagaki, H Yamazaki, T Wakita, JE Ware, J Wang… - BMJ Open, 2023 - ncbi.nlm.nih.gov
Introduction Hyperkalaemia (HK) is a frequent complication in patients with chronic kidney
disease (CKD) and/or chronic heart failure (CHF). HK must be managed, both to protect …

Acute Hyperkalemia Management in the Emergency Department

KA Weant, H Gregory - Advanced Emergency Nursing Journal, 2024 - journals.lww.com
Acute hyperkalemia is characterized by high concentrations of potassium in the blood that
can potentially lead to life-threatening arrhythmias that require emergent treatment. Therapy …

Efficacy and Safety of Patiromer for Chronic Hyperkalemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

HA Cheema, A Shafiee, MMT Athar… - American Journal of …, 2024 - journals.lww.com
To the Editor: Hyperkalemia is a potentially life-threatening electrolyte disorder
disproportionally affecting patients with chronic kidney disease (CKD) and heart failure (HF) …